Brief: Tempus Announces Multi-Year Collaboration With Moderna And Merck
BRIEF-Tempus Announces Multi-Year Collaboration With Moderna And Merck Oct 7 (Reuters) - Tempus AI, Inc. TEM.O:
TEMPUS ANNOUNCES MULTI-YEAR COLLABORATION WITH MODERNA AND MERCK
TEMPUS - ANNOUNCES EXPANDED MULTI-YEAR COLLABORATION FOR INTISMERAN AUTOGENE COMMERCIALIZATION
TEMPUS - FINANCIAL TERMS OF COLLABORATION NOT DISCLOSED
TEMPUS: TO MANAGE COLLECTION & TRANSFER OF TUMOR TISSUE & BLOOD SAMPLES NEEDED FOR NEXT-GENERATION SEQUENCING
TEMPUS: TO ALSO PROVIDE NGS SERVICES TO SUPPORT INTISMERAN AUTOGENE DESIGN AND MANUFACTURING PROCESS
Source text: ID:nBw1MMdJ5a
Further company coverage: TEM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempus AI
See all newsU.S. STOCKS ON THE MOVE-Tempus AI, Choice Hotels, Palantir
Tempus AI rises after surprise quarterly profit
Tempus AI Q3 revenue slightly beats estimates; raises guidance
Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb